New immune cell therapy benefits laboratory models of ALS and has some positive results in an individual with the disease Post author: Post published:July 11, 2024 Post category:News Feed Post comments:0 Comments The study provides the basis for a phase I clinical trial in additional participants. You Might Also Like Candidate deafness genes revealed in new study April 14, 2025 Getting a better look at tumors January 6, 2024 Genes or environment? A new model for understanding disease risk factors July 31, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.